Genomic Vision (GV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
July 2018
28
About the Report
About the Report
Summary
Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company's portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomic's technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements. Genomic is headquartered in Paris, France.
Genomic Vision (GV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Genomic Vision, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genomic Vision, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genomic Vision, Medical Devices Deals, 2012 to YTD 2018 9
Genomic Vision, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genomic Vision, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genomic Vision Enters into Partnership with AstraZeneca 11
Genomic Vision Enters into Agreement with Reims University Hospital 12
Genomic Vision Enters into Agreement with Rouen University Hospital 13
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 14
Genomic Vision-Key Competitors 15
Genomic Vision-Key Employees 16
Genomic Vision-Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Jan 17, 2018: Genomic Vision: 2017 Annual Revenue from Sales: +36% to EUR2.1 Million 18
Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to EUR1.3 Million 19
Jul 25, 2017: Genomic Vision: First half 2017 results 20
May 09, 2017: Genomic Vision: Financial Information at March 31, 2017 22
Mar 01, 2017: Genomic Vision: 2016 Annual Results 23
Government and Public Interest 26
Jul 05, 2018: Genomic Vision Provides an Update on Its Commercial Development and Financial Situation 26
Other Significant Developments 27
Jan 09, 2017: Genomic Vision Doubles Its Installed Base of FiberVision Platforms and Quadruples Its Sales of Products and Services in 2016 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Figure
List of Figures
Genomic Vision, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genomic Vision, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genomic Vision, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Genomic Vision, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genomic Vision, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genomic Vision, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genomic Vision, Deals By Therapy Area, 2012 to YTD 2018 8
Genomic Vision, Medical Devices Deals, 2012 to YTD 2018 9
Genomic Vision, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genomic Vision Enters into Partnership with AstraZeneca 11
Genomic Vision Enters into Agreement with Reims University Hospital 12
Genomic Vision Enters into Agreement with Rouen University Hospital 13
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 14
Genomic Vision, Key Competitors 15
Genomic Vision, Key Employees 16
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.